Martin A Osterhoff
Overview
Explore the profile of Martin A Osterhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer N, Kabisch S, Dambeck U, Honsek C, Kemper M, Gerbracht C, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928106
Lifestyle interventions can prevent type 2 diabetes (T2DM). However, some individuals do not experience anticipated improvements despite weight loss. Biomarkers to identify such individuals at early stages are lacking. Insulin-like...
2.
Kruse M, Hornemann S, Ost A, Frahnow T, Hoffmann D, Busjahn A, et al.
Nutrients
. 2023 May;
15(10).
PMID: 37242220
Background: The dysfunction of energy metabolism in white adipose tissue (WAT) induces adiposity. Obesogenic diets that are high in saturated fat disturb nutrient metabolism in adipocytes. This study investigated the...
3.
Kabisch S, Meyer N, Honsek C, Kemper M, Gerbracht C, Arafat A, et al.
Nutrients
. 2022 Nov;
14(22).
PMID: 36432409
Background: T2DM heterogeneity affects responsiveness to lifestyle treatment. Beta-cell failure and nonalcoholic fatty liver disease (NAFLD) independently predict T2DM, but NAFLD inconsistently predicts metabolic response to lifestyle intervention. Aim: We...
4.
Meyer N, Kabisch S, Dambeck U, Honsek C, Kemper M, Gerbracht C, et al.
Eur J Endocrinol
. 2022 Aug;
187(4):555-565.
PMID: 36005859
Objectives: Some individuals develop type 2 diabetes mellitus (T2DM) despite significant metabolic improvements through lifestyle intervention. We tested the hypotheses that insulin growth factor 1 (IGF1) and its binding proteins...
5.
Kabisch S, Honsek C, Kemper M, Gerbracht C, Arafat A, Birkenfeld A, et al.
Acta Diabetol
. 2021 Jul;
58(12):1649-1658.
PMID: 34254189
Aims: As the first long-term RCT on insoluble cereal fibre, the optimal fibre trial demonstrated glycometabolic benefits, confirming cohort studies. The combined study intervention of lifestyle recommendations and supplementation with...
6.
Kabisch S, Honsek C, Kemper M, Gerbracht C, Meyer N, Arafat A, et al.
Mol Nutr Food Res
. 2021 Apr;
65(12):e2000991.
PMID: 33909947
Scope: The Optimal Fibre Trial (OptiFiT) investigates metabolic effects of insoluble cereal fibre in subjects with impaired glucose tolerance (IGT), showing moderate glycemic and anti-inflammatory benefits, especially in subjects with...
7.
Schuler R, Markova M, Osterhoff M, Arafat A, Pivovarova O, Machann J, et al.
Eur J Nutr
. 2021 Mar;
60(6):3499-3504.
PMID: 33686453
Increased animal but not plant protein intake has been associated with increased mortality in epidemiological studies in humans and with reduced lifespan in animal species. Protein intake increases the activity...
8.
Kruse M, Keyhani-Nejad F, Osterhoff M, Pfeiffer A
Peptides
. 2020 Jan;
125:170250.
PMID: 31917165
Obesity has a multifactorial origin. It is known that alterations of the intra uterine milieu induce developmental programming effects leading to metabolic diseases in offspring. Obesity is diminished in mice...
9.
Kabisch S, Meyer N, Honsek C, Gerbracht C, Dambeck U, Kemper M, et al.
Nutrients
. 2019 Nov;
11(11).
PMID: 31717901
Background: OptiFiT demonstrated the beneficial effect of insoluble oat fibres on dysglycemia in prediabetes. Recent analyses of OptiFiT and other randomised controlled trials (RCTs) indicated that this effect might be...
10.
Kabisch S, Meyer N, Honsek C, Gerbracht C, Dambeck U, Kemper M, et al.
Nutrients
. 2019 Oct;
11(10).
PMID: 31590438
Background: High intake of cereal fibre is associated with reduced risk for type 2 diabetes and long-term complications. Within the first long-term randomized controlled trial specifically targeting cereal fibre, the...